期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

分枝杆菌检测在生物制品质量控制中的应用 被引量：1

Application of mycobacteria detection in quality control of biological products
原文传递
导出
摘要 根据世界卫生组织和美国食品药品管理局对生物制品中分枝杆菌检测的最新要求，乙型脑炎减毒活疫苗质量控制中首次增加了分枝杆菌检测项目。此文概述了分枝杆菌的特性和分类、不同种类分枝杆菌的致病性以及分枝杆菌检测的常用技术，并介绍了在乙型脑炎减毒活疫苗质量控制中检测分枝杆菌的不同方法。核酸扩增法检测分枝杆菌是我国首次用于生物制品质量控制。 According to the latest requirements of World Health Organization and U. S. Food and Drug Administration for detecting mycobacteria in biological products, mycobaeteria detection is first added to quality control of live attenuated Japanese encephalitis vaccine. This article reviews classification and characteristics of myeobacteria, pathogenicity of different kinds of myeobacteria and common technology for detecting myeobaeteria, and introduces different methods for detecting mycobaeteria in quality control of Japanese encephalitis vaccine. Nucleic acid amplification assay for detecting mycobacteria is first applied to quality control of biological products in our country.
作者 王静(综述) 孟丽(综述) 姚亚夫(审校)
机构地区 成都生物制品研究所有限责任公司质量检定室 成都生物制品研究所有限责任公司质量保证部 成都生物制品研究所有限责任公司所长办公室
出处 《国际生物制品学杂志》 CAS 2013年第3期141-145,共5页 International Journal of Biologicals
关键词 分枝杆菌 生物制品 质量控制 日本脑炎疫苗 Myeobacterium Biological products Quality control Japanese encephalitis vaccines
分类号 R [医药卫生]
  • 相关文献

参考文献14

  • 1张天民.结核分枝杆菌复合群的进展和新成员[J].结核病与胸部肿瘤,2005(3):222-225. 被引量：4
  • 2World Health Organization. The world health report 1999--making a difference [ EB/OL]. [ 2013-01-02 ]. http://www, who. int/ whr/1999/en/index, html.
  • 3冯经华,尹凤鸣,严振球.目前结核分枝杆菌感染中重要免疫细胞和细胞因子作用的研究进展[J].临床军医杂志,2007,35(2):291-295. 被引量：16
  • 4王巍.重视非结核分枝杆菌病诊断和治疗的研究[J].传染病信息,2009,22(1):14-17. 被引量：22
  • 5World Health Organization. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks [ EB/ OL]. [2013-01-02]. http: // www. who. int/biologicals/ vaccines/cell_ substrates/en/index, html.
  • 6World Health Organization. Guidelines on the quality, safety and efficacy of Japanese encephalitis vaccines ( live, attenuated ) for human use [ EB/OL]. [2013-01-02]. http: //www. who. int/ entity/biologicals/WHO_ JE_live _RE _v1. 8.6. pdf.
  • 7World Health Organization. Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines ( live, attenuated ) [ EB/ OL]. [2013-01-02]. http: // www. who. int/biologicals/ publication/trs/areas/vaccines/dengue/en/ index, html.
  • 8World Health Organization. WHO Recommendations to assure the quality, safety, and efficacy of influenza vaccines ( human, live attenuated) for intranasal administration [ EB/OL]. [ 2013-01- 02 ]. http: // www. who. int/ biologicals/vaccines/influenza/en/ index, html.
  • 9U.S. Food and Drag Administration. Characterization and qualifi- cation of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications [ EB/ OL]. [2013-01-02]. http: //www, fda. gov/BiologicalsBloodVac- cines/GuidanceComplianceRegulatorylnformation/Guidances/de- fault, htm.
  • 10陈全,朱道银.用抗原诊断结核分枝杆菌感染的免疫学研究进展[J].国际检验医学杂志,2004,26(5):456-459. 被引量：3

二级参考文献109

  • 1潘家华,楼皖玲,周浩泉,沈怀云,陈兰举.卡介苗配用腺苷接种提高巨噬细胞抗结核杆菌效能的研究[J].中华儿科杂志,2004,42(12):932-935. 被引量：6
  • 2沈国妙,查佳,徐琳,孙斌,桂晓红,王奕峰,梅建,高谦.结核分枝杆菌散在分布重复单位基因型分型法的应用研究[J].中华结核和呼吸杂志,2005,28(5):292-296. 被引量：28
  • 3Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontubereulous myeobacterial diseases [J]. Am J Respir Crit Care Med, 2007,175(4):367-416.
  • 4Aksamit TR. Hot tub lung: infection, inflammation, or both? [J]. Semin Respir Infect, 2003,18(1):33-39.
  • 5Marras TK, Wallace RJ Jr, Koth LL, et al. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water [J]. Chest, 2005,127(2):664-671.
  • 6Falkinham JO 3rd. Nontuberculous mycobacteria in the environment[J]. Clin Chest Med, 2002,23(3):529-551.
  • 7Olivier KN, Weber D J, Wallace RJ Jr, et al. Nontuberculous mycobacteria Ⅰ: muhicenter prevalence study in cystic fibrosis[J]. Am J Respir Crit Care Med, 2003,167(6):825-834.
  • 8Shin JH, Lee E J, Lee HR, et al. Prevalence of non-tuberculous mycobacteria in a hospital environment[J]. J Hosp Infect, 2007,65(2): 143-148.
  • 9Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/ pseudo-outbreaks caused by nontuberculous mycobacteria [J]. Annu Rev Microbiol, 1998,52:453-490.
  • 10Horsburgh CR Jr. Epidemiology of disease caused by nontuberculous mycobacteria[J]. Semin Respir Infect, 1996, 11 (4): 244-251.

共引文献293

同被引文献9

  • 1中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 2WHO. The world health report 1999 : making a difference [R]. Geneva: WHO, 1999: 110.
  • 3U.S.Food and Drug Administration.Characterization and quali- fication of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indica- tions [ EB / OL ]. ( 2013-01-02 ) [ 2013-05-26 ]. http:/! www.fda. gov / BiologicalsBloodVaccines / GuidanceCompliance Regulatory Information / Guidances / defauh.htm.
  • 4WHO. Guidelines on the quality, safety and efficacy of Japanese encephalitis vaccines (live, attenuated) for human use [ S ]. Ge- neva: WHO. 2012.
  • 5Tobler NE, Pfunder M, Herzog K, et al. Rapid detection and species identification of Mycobacterium spp. using real-time PCR and DNA-microarray [J]. J Microbiol Methods, 2006, 66 (1): 116-124.
  • 6王亚娟,冯萍,熊礼宽.分枝杆菌鉴定的分子生物学方法研究进展[J].临床肺科杂志,2009,14(3):353-355. 被引量：17
  • 7戴广明,曹以诚,杜正平,陈洵,黄曙海,逄宇,周杨,黄海荣,赵雁林.结核分枝杆菌环介导恒温扩增(LAMP)快速检测方法的评价[J].中国防痨杂志,2011,33(1):47-51. 被引量：14
  • 8张苑怡,武娜,朱宝利,陈蕾,朱玉琢.快速检测NDM-1基因的环介导恒温扩增技术的建立与评价[J].生物工程学报,2011,27(8):1232-1238. 被引量：11
  • 9白云,万康林.结核分枝杆菌分子进化研究进展[J].中国人兽共患病学报,2012,28(5):483-486. 被引量：1

引证文献1

国际生物制品学杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部